|
1
|
Kaatsch P, Rickert CH, Kühl J, Schüz J and
Michaelis J: Population-based epidemiologic data on brain tumors in
German children. Cancer. 92:3155–3164. 2001.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Ostrom QT, Gittleman H, Farah P, Ondracek
A, Chen Y, Wolinsky Y, Stroup NE, Kruchko C and Barmholtz-Sloan JS:
CBTRUS statistical report: Primary brain and central nervous system
tumors diagnosed in the United States in 2006-2010. Neuro Oncol. 15
(Suppl 2):ii1–ii56. 2013.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Walston S, Hamstra DA, Oh K, Woods G,
Guiou M, Olshefski RS, Chakravarti A and Williams TM: A
multi-institutional experience in pediatric high-grade glioma.
Front Oncol. 5(28)2015.PubMed/NCBI View Article : Google Scholar
|
|
4
|
MacDonald TJ, Aguilera D and Kramm CM:
Treatment of high-grade glioma in children and adolescents. Neuro
Oncol. 13:1049–1058. 2011.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Giannopoulos S and Kyritsis AP: Diagnosis
and management of multifocal gliomas. Oncology. 79:306–312.
2010.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Hassaneen W, Levine NB, Suki D, Salaskar
AL, de Moura Lima A, McCutcheon IE, Prabhu SS, Lang FF, DeMonte F,
Rao G, et al: Multiple craniotomies in the management of multifocal
and multicentric glioblastoma. Clinical article. J Neurosurg.
114:576–584. 2011.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Lasocki A, Gaillard F, Tacey M, Drummond K
and Stuckey S: Multifocal and multicentric glioblastoma: Improved
characterisation with FLAIR imaging and prognostic implications. J
Clin Neurosci. 31:92–98. 2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Stupp R, Mason WP, van den Bent MJ, Weller
M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn
U, et al: Radiotherapy plus concomitant and adjuvant temozolomide
for glioblastoma. N Engl J Med. 352:987–996. 2005.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Tamber MS and Rutka JT: Pediatric
supratentorial high-grade gliomas. Neurosurg Focus.
14(e1)2003.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Korshunov A, Ryzhova M, Hovestadt V,
Bender S, Strum D, Capper D, Meyer J, Schrimpf D, Kool M, Northcott
PA, et al: Integrated analysis of pediatric glioblastoma reveals a
subset of biologically favorable tumors with associated molecular
prognostic markers. Acta Neuropathol. 129:669–678. 2015.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Lam S, Lin Y, Zinn P, Su J and Pan IW:
Patient and treatment factors associated with survival among
pediatric glioblastoma patients: A surveillance, epidemiology, and
end results study. J Clin Neurosci. 47:285–293. 2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Pollack IF, Hamilton RL, Burger PC, Brat
DJ, Rosenblum MK, Murdoch GH, Nikiforova MN, Holmes EJ, Zhou T,
Cohen KJ, et al: Akt activation is a common event in pediatric
malignant gliomas and a potential adverse prognostic marker: A
report from the children's oncology group. J Neurooncol.
99:155–163. 2010.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Antonelli M, Buttarelli FR, Arcella A,
Nobusawa S, Donofrio V, Oghaki H and Giangaspero F: Prognostic
significance of histological grading, p53 status, YKL-40
expression, and IDH1 mutations in pediatric high-grade gliomas. J
Neurooncol. 99:209–215. 2010.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Pollack IF, Finkelstein SD, Woods J,
Burnham J, Holmes EJ, Hamilton RL, Yates AJ, Boyett JM, Finlay JL
and Sposto R: Children's Cancer Group. Expression of p53 and
prognosis in children with malignant gliomas. N Engl J Med.
346:420–427. 2002.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Syed M, Liermann J, Verma V, Bernhardt D,
Bougatf N, Paul A, Rieken S, Debus J and Adeberg S: Survival and
recurrence patterns of multifocal glioblastoma after radiation
therapy. Cancer Manag Res. 10:4229–4235. 2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Liu M, Thakkar JP, Garcia CR, Dolecek TA,
Wagner LM, Dressler EVM and Villano JL: National cancer database
analysis of outcomes in pediatric glioblastoma. Cancer Med.
7:1151–1159. 2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Bouffet E, Larouche V, Campbell BB, Merico
D, de Borja R, Aronson M, Durno C, Krueger J, Cabric V, Ramaswamy
V, et al: Immune checkpoint inhibition for hypermutant glioblastoma
multiforme resulting from germline biallelic mismatch repair
deficiency. J Clin Oncol. 34:2206–2211. 2016.PubMed/NCBI View Article : Google Scholar
|
